Cite
HARVARD Citation
Petzold, A. et al. (2022). Comparative efficacy analysis identifies immune checkpoint blockade as a new survival benchmark in advanced cutaneous squamous cell carcinoma. European journal of cancer. pp. 42-53. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Petzold, A. et al. (2022). Comparative efficacy analysis identifies immune checkpoint blockade as a new survival benchmark in advanced cutaneous squamous cell carcinoma. European journal of cancer. pp. 42-53. [Online].